Molecular Mechanisms and Pharmacological Underlying Cardiorenal Diseases
A special issue of Current Issues in Molecular Biology (ISSN 1467-3045). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: closed (31 October 2025) | Viewed by 531
Special Issue Editor
Interests: nephrocardiology; chronic renal failure; hypertension
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
A growing body of medical literature underscores the intricate relationship between the heart and kidneys, both in terms of their physiological functions and underlying molecular mechanisms. It is becoming increasingly clear that cardiology and nephrology are closely interconnected, and numerous studies emphasize the need for a collaborative and interdisciplinary approach to understanding these interactions. Moreover, the rising prevalence of diabetes has exacerbated this relationship within the broader context of cardio-renal-metabolic syndrome.
Pharmacological and molecular research has yielded innovative therapeutic agents that show promise in addressing the complex interplay between these organs. In this Special Issue, we aim to deepen our understanding of the pharmacological and molecular mechanisms underlying cardio-renal disease, with a focus on the development of novel drug targets and therapeutic strategies.
We invite your valuable contributions to this exciting area of research, as we strive to expand our knowledge and enhance therapeutic approaches to treating cardio-renal dysfunction at the molecular level.
Dr. Caterina Carollo
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Issues in Molecular Biology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hypertension
- cardio-renal syndromes
- heart failure
- chronic kidney disease
- hemodialysis
- periotenal dialysis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
